Kocatepe Veterinary Journal, cilt.18, sa.3, ss.1-13, 2025 (TRDizin)
Rabbits fed a
high cholesterol diet (HCD) exhibit various physiopathologic features of
hepatic lipidosis. This study aimed to investigate the effects of thyme oil
(TO) and thymol (T) on inflammation-related hepatic gene expression in a rabbit
model of high cholesterol diet–induced hepatic lipidosis. Male New Zealand
rabbits were divided into six groups. The groups were: Standard rabbit diet
(SD, n= 8), Standard rabbit diet + thymol (SD+T, n= 8), Standard rabbit diet +
thyme oil (SD+TO, n= 8), High cholesterol diet (HCD, n=8), High cholesterol
diet + thymol (HCD+T, n= 8), and High cholesterol diet + thyme oil (HCD+TO, n=
8). Blood samples were collected at weeks 0, 4, 8, and 11 of the study. Total cholesterol
(TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), and triglyceride (TG) levels were analyzed. The mRNA
expression levels of inflammation-related genes from liver tissue were analyzed
by the real-time polymerase chain reaction (RT-PCR) method. The expression levels
of interleukin 4 (IL4), IL17 and interferon gamma
(IFNγ) genes were lower, whereas the
expression levels of IL9, IL13, IL18 and RAR-related orphan
receptor gamma (RORγ) genes were
higher in rabbits fed with HCD compared to the normal diet group (p < 0.05).
Thymol increased T-box transcription
factor (Tbet), IL4, IL17A,
and IL18 gene expression. Thyme oil
increased GATA-binding protein 3 (Gata3) and IL18 gene
expression. In conclusion, an HCD successfully established a non-obese rabbit
model of hepatic lipidosis characterized by microvesicular steatosis, liver
injury, and immune gene alterations. Thyme oil and thymol modulated immune
responses by affecting key cytokine expressions but did not improve lipid
profiles or liver histopathology. These results suggest that the
immunomodulatory effects of thyme compounds are complex and their therapeutic
potential may depend on specific disease contexts and treatment parameters.
Further research is needed to clarify their role in hepatic lipidosis
management.